vs
ExlService Holdings, Inc.(EXLS)与SelectQuote, Inc.(SLQT)财务数据对比。点击上方公司名可切换其他公司
ExlService Holdings, Inc.的季度营收约是SelectQuote, Inc.的1.0倍($542.6M vs $537.1M),SelectQuote, Inc.净利率更高(12.9% vs 11.1%,领先1.8%),ExlService Holdings, Inc.同比增速更快(12.7% vs 11.6%),ExlService Holdings, Inc.自由现金流更多($106.5M vs $-1.0M),过去两年SelectQuote, Inc.的营收复合增速更高(19.5% vs 11.5%)
ExlService Holdings Inc.是全球知名的分析与数字解决方案服务商,服务覆盖保险、医疗健康、银行金融服务、媒体、零售等多个行业,总部位于纽约,在美国、欧洲、亚洲、拉美、澳大利亚、南非等地拥有超过5.4万名专业从业人员。
SelectQuote是面向消费者的直售平台,主营保险产品与医疗服务业务,通过对接消费者与保险机构获取佣金,覆盖长者健康险、人寿险、车险、家财险等品类,医疗服务板块以认证药房SelectRx为核心业务,公司于2020年5月上市。
EXLS vs SLQT — 直观对比
营收规模更大
EXLS
是对方的1.0倍
$537.1M
营收增速更快
EXLS
高出1.1%
11.6%
净利率更高
SLQT
高出1.8%
11.1%
自由现金流更多
EXLS
多$107.5M
$-1.0M
两年增速更快
SLQT
近两年复合增速
11.5%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $542.6M | $537.1M |
| 净利润 | $60.2M | $69.3M |
| 毛利率 | 38.6% | 61.8% |
| 营业利润率 | 14.4% | 14.0% |
| 净利率 | 11.1% | 12.9% |
| 营收同比 | 12.7% | 11.6% |
| 净利润同比 | 18.9% | 30.2% |
| 每股收益(稀释后) | $0.38 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EXLS
SLQT
| Q4 25 | $542.6M | $537.1M | ||
| Q3 25 | $529.6M | $328.8M | ||
| Q2 25 | $514.5M | $345.1M | ||
| Q1 25 | $501.0M | $408.2M | ||
| Q4 24 | $481.4M | $481.1M | ||
| Q3 24 | $472.1M | $292.3M | ||
| Q2 24 | $448.4M | $307.2M | ||
| Q1 24 | $436.5M | $376.4M |
净利润
EXLS
SLQT
| Q4 25 | $60.2M | $69.3M | ||
| Q3 25 | $58.2M | $-30.5M | ||
| Q2 25 | $66.1M | $12.9M | ||
| Q1 25 | $66.6M | $26.0M | ||
| Q4 24 | $50.7M | $53.2M | ||
| Q3 24 | $53.0M | $-44.5M | ||
| Q2 24 | $45.8M | $-31.0M | ||
| Q1 24 | $48.8M | $8.6M |
毛利率
EXLS
SLQT
| Q4 25 | 38.6% | 61.8% | ||
| Q3 25 | 38.5% | 41.4% | ||
| Q2 25 | 37.7% | 47.2% | ||
| Q1 25 | 38.6% | 60.2% | ||
| Q4 24 | 38.1% | 67.5% | ||
| Q3 24 | 37.8% | 55.7% | ||
| Q2 24 | 37.1% | 60.7% | ||
| Q1 24 | 37.4% | 71.8% |
营业利润率
EXLS
SLQT
| Q4 25 | 14.4% | 14.0% | ||
| Q3 25 | 14.4% | -12.4% | ||
| Q2 25 | 15.8% | -3.6% | ||
| Q1 25 | 15.7% | 5.4% | ||
| Q4 24 | 14.8% | 14.7% | ||
| Q3 24 | 14.7% | -4.1% | ||
| Q2 24 | 13.7% | -0.5% | ||
| Q1 24 | 14.1% | 8.8% |
净利率
EXLS
SLQT
| Q4 25 | 11.1% | 12.9% | ||
| Q3 25 | 11.0% | -9.3% | ||
| Q2 25 | 12.8% | 3.7% | ||
| Q1 25 | 13.3% | 6.4% | ||
| Q4 24 | 10.5% | 11.1% | ||
| Q3 24 | 11.2% | -15.2% | ||
| Q2 24 | 10.2% | -10.1% | ||
| Q1 24 | 11.2% | 2.3% |
每股收益(稀释后)
EXLS
SLQT
| Q4 25 | $0.38 | $0.26 | ||
| Q3 25 | $0.36 | $-0.26 | ||
| Q2 25 | $0.40 | $-0.06 | ||
| Q1 25 | $0.40 | $0.03 | ||
| Q4 24 | $0.31 | $0.30 | ||
| Q3 24 | $0.33 | $-0.26 | ||
| Q2 24 | $0.28 | $-0.17 | ||
| Q1 24 | $0.29 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $328.4M | $18.3M |
| 总债务越低越好 | $298.6M | $405.8M |
| 股东权益账面价值 | $912.7M | $359.7M |
| 总资产 | $1.7B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.33× | 1.13× |
8季度趋势,按日历期对齐
现金及短期投资
EXLS
SLQT
| Q4 25 | $328.4M | $18.3M | ||
| Q3 25 | $390.1M | $10.7M | ||
| Q2 25 | $353.3M | $32.4M | ||
| Q1 25 | $331.4M | $80.1M | ||
| Q4 24 | $340.6M | $7.3M | ||
| Q3 24 | $325.8M | $10.4M | ||
| Q2 24 | $276.1M | $42.7M | ||
| Q1 24 | $246.2M | $37.8M |
总债务
EXLS
SLQT
| Q4 25 | $298.6M | $405.8M | ||
| Q3 25 | $354.8M | $393.1M | ||
| Q2 25 | $260.0M | $385.1M | ||
| Q1 25 | $307.3M | $391.5M | ||
| Q4 24 | $288.5M | $711.9M | ||
| Q3 24 | $344.7M | $680.4M | ||
| Q2 24 | — | $683.3M | ||
| Q1 24 | — | $686.0M |
股东权益
EXLS
SLQT
| Q4 25 | $912.7M | $359.7M | ||
| Q3 25 | $952.4M | $305.1M | ||
| Q2 25 | $1.1B | $351.1M | ||
| Q1 25 | $1.0B | $350.2M | ||
| Q4 24 | $929.9M | $326.0M | ||
| Q3 24 | $907.6M | $269.4M | ||
| Q2 24 | $852.6M | $316.8M | ||
| Q1 24 | $803.3M | $346.8M |
总资产
EXLS
SLQT
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.4B | $1.2B |
负债/权益比
EXLS
SLQT
| Q4 25 | 0.33× | 1.13× | ||
| Q3 25 | 0.37× | 1.29× | ||
| Q2 25 | 0.25× | 1.10× | ||
| Q1 25 | 0.30× | 1.12× | ||
| Q4 24 | 0.31× | 2.18× | ||
| Q3 24 | 0.38× | 2.53× | ||
| Q2 24 | — | 2.16× | ||
| Q1 24 | — | 1.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $117.4M | $52.0K |
| 自由现金流经营现金流 - 资本支出 | $106.5M | $-1.0M |
| 自由现金流率自由现金流/营收 | 19.6% | -0.2% |
| 资本支出强度资本支出/营收 | 2.0% | 0.2% |
| 现金转化率经营现金流/净利润 | 1.95× | 0.00× |
| 过去12个月自由现金流最近4个季度 | $298.1M | $8.5M |
8季度趋势,按日历期对齐
经营现金流
EXLS
SLQT
| Q4 25 | $117.4M | $52.0K | ||
| Q3 25 | $120.7M | $-21.6M | ||
| Q2 25 | $109.4M | $-37.5M | ||
| Q1 25 | $3.2M | $71.1M | ||
| Q4 24 | $105.3M | $-28.7M | ||
| Q3 24 | $110.1M | $-16.6M | ||
| Q2 24 | $74.9M | $20.0M | ||
| Q1 24 | $-21.9M | $44.5M |
自由现金流
EXLS
SLQT
| Q4 25 | $106.5M | $-1.0M | ||
| Q3 25 | $106.4M | $-22.7M | ||
| Q2 25 | $95.0M | $-38.0M | ||
| Q1 25 | $-9.7M | $70.2M | ||
| Q4 24 | $95.3M | $-29.0M | ||
| Q3 24 | $97.3M | $-17.1M | ||
| Q2 24 | $62.8M | $19.7M | ||
| Q1 24 | $-33.1M | $43.4M |
自由现金流率
EXLS
SLQT
| Q4 25 | 19.6% | -0.2% | ||
| Q3 25 | 20.1% | -6.9% | ||
| Q2 25 | 18.5% | -11.0% | ||
| Q1 25 | -1.9% | 17.2% | ||
| Q4 24 | 19.8% | -6.0% | ||
| Q3 24 | 20.6% | -5.8% | ||
| Q2 24 | 14.0% | 6.4% | ||
| Q1 24 | -7.6% | 11.5% |
资本支出强度
EXLS
SLQT
| Q4 25 | 2.0% | 0.2% | ||
| Q3 25 | 2.7% | 0.3% | ||
| Q2 25 | 2.8% | 0.1% | ||
| Q1 25 | 2.6% | 0.2% | ||
| Q4 24 | 2.1% | 0.1% | ||
| Q3 24 | 2.7% | 0.2% | ||
| Q2 24 | 2.7% | 0.1% | ||
| Q1 24 | 2.6% | 0.3% |
现金转化率
EXLS
SLQT
| Q4 25 | 1.95× | 0.00× | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.66× | -2.91× | ||
| Q1 25 | 0.05× | 2.73× | ||
| Q4 24 | 2.08× | -0.54× | ||
| Q3 24 | 2.08× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | 5.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
SLQT
| Healthcare Services Segment | $230.7M | 43% |
| Pharmacy | $227.2M | 42% |
| Other | $30.4M | 6% |
| Final Expense | $20.4M | 4% |
| Term | $18.5M | 3% |
| Other Senior | $6.3M | 1% |
| All Other Revenue | $3.9M | 1% |